Effects of Cannabidiol on Locomotor Activity.
cannabidiol
cannabis
locomotion
locomotor activity
motor activity
Journal
Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444
Informations de publication
Date de publication:
27 Apr 2022
27 Apr 2022
Historique:
received:
24
03
2022
revised:
23
04
2022
accepted:
26
04
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
Cannabidiol (CBD) is the second cannabinoid, in order of importance after Δ9-tetrahydrocannabinol (THC), from
Identifiants
pubmed: 35629320
pii: life12050652
doi: 10.3390/life12050652
pmc: PMC9144881
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Cell Death Dis. 2013 Dec 05;4:e949
pubmed: 24309936
Br J Pharmacol. 2018 Jan;175(1):100-112
pubmed: 29057454
Eur J Pharmacol. 2003 Feb 28;463(1-3):55-65
pubmed: 12600702
Acta Pharmacol Sin. 2019 Mar;40(3):358-364
pubmed: 30022153
Physiol Res. 1995;44(3):143-50
pubmed: 8869270
Neurogastroenterol Motil. 2008 Aug;20(8):919-27
pubmed: 18373655
ACS Chem Neurosci. 2014 Nov 19;5(11):1131-41
pubmed: 25029033
J Neurosci. 2009 Feb 18;29(7):2053-63
pubmed: 19228959
Eur J Pharmacol. 2021 Jan 15;891:173767
pubmed: 33275960
Neurotherapeutics. 2021 Jan;18(1):615-623
pubmed: 33230690
Molecules. 2019 Sep 26;24(19):
pubmed: 31561446
Br J Pharmacol. 2015 Apr;172(7):1783-91
pubmed: 25425111
Drug Alcohol Depend. 2021 Apr 1;221:108629
pubmed: 33640678
Front Behav Neurosci. 2019 Feb 20;13:32
pubmed: 30842732
Chemosphere. 2022 Feb;289:133012
pubmed: 34838836
Eur J Pharmacol. 2011 Mar 25;655(1-3):38-45
pubmed: 21266173
Cannabis Cannabinoid Res. 2017 Jun 01;2(1):139-154
pubmed: 28861514
Cancer Treat Res Commun. 2021;26:100278
pubmed: 33360668
Neuropharmacology. 2017 Oct;125:319-332
pubmed: 28807673
Psychol Bull. 1976 May;83(3):482-504
pubmed: 17582919
Br J Pharmacol. 2008 Jan;153(2):199-215
pubmed: 17828291
Sports Med Open. 2020 Jul 6;6(1):27
pubmed: 32632671
J Hepatol. 2009 Sep;51(3):528-34
pubmed: 19596476
Life Sci. 2020 Oct 15;259:118271
pubmed: 32798553
Molecules. 2020 Jun 05;25(11):
pubmed: 32517131
Brain Sci. 2020 Sep 16;10(9):
pubmed: 32947873
Front Neurol. 2018 Mar 22;9:183
pubmed: 29623067
Molecules. 2020 Oct 25;25(21):
pubmed: 33113776
Int J Mol Sci. 2021 Sep 03;22(17):
pubmed: 34502487
Biochem Pharmacol. 2021 Mar;185:114433
pubmed: 33513342
Life Sci. 1998;63(1):PL1-6
pubmed: 9667767
Immunobiology. 2010 Aug;215(8):611-6
pubmed: 19833407
Front Pharmacol. 2017 Feb 03;8:20
pubmed: 28217094
World J Biol Psychiatry. 2020 Oct;21(8):612-626
pubmed: 32264772
Tetrahedron. 1963 Dec;19(12):2073-8
pubmed: 5879214
Bioorg Med Chem. 2015 Apr 1;23(7):1377-85
pubmed: 25703248
Drug Alcohol Depend. 2017 Jun 1;175:187-197
pubmed: 28445853
Chem Biodivers. 2007 Aug;4(8):1678-92
pubmed: 17712814
Cannabis Cannabinoid Res. 2016 Mar 01;1(1):90-101
pubmed: 28861484
J Pharm Sci. 1973 Jul;62(7):1083-6
pubmed: 4351642
J Diet Suppl. 2020;17(5):487-492
pubmed: 32715797
Clin Pharmacokinet. 2003;42(4):327-60
pubmed: 12648025
Ital J Pediatr. 2017 Apr 19;43(1):39
pubmed: 28420439
J Pharmacol Methods. 1991 Apr;25(2):111-22
pubmed: 2067382
Front Behav Neurosci. 2019 May 07;13:94
pubmed: 31133833
Basic Clin Pharmacol Toxicol. 2022 Apr;130(4):439-456
pubmed: 35083862
Cannabis Cannabinoid Res. 2021 Dec;6(6):451-456
pubmed: 33998850
Proc Natl Acad Sci U S A. 2017 Oct 17;114(42):11229-11234
pubmed: 28973916
Mult Scler Relat Disord. 2018 Oct;25:200-207
pubmed: 30103172
Psychopharmacology (Berl). 2016 Jan;233(2):243-54
pubmed: 26439367
J Vis Exp. 2017 Aug 30;(126):
pubmed: 28892027
Issues Emerg Health Technol. 2005 Sep;(72):1-4
pubmed: 16317825
J Pharmacol Exp Ther. 2012 Mar;340(3):787-800
pubmed: 22182934
Evid Based Complement Alternat Med. 2019 Aug 29;2019:2509129
pubmed: 31558911
Exp Neurol. 2001 Jun;169(2):425-37
pubmed: 11358456
Front Pharmacol. 2016 Sep 28;7:343
pubmed: 27733830
Pain. 2019 Jan;160(1):136-150
pubmed: 30157131
Br J Pharmacol. 2015 Feb;172(3):737-53
pubmed: 25257544
Neurosci Lett. 2013 Dec 17;557 Pt B:84-9
pubmed: 24176881
Clin Pharmacol Ther. 2021 Nov;110(5):1368-1380
pubmed: 34464454
Psychopharmacology (Berl). 2018 Sep;235(9):2541-2557
pubmed: 29907926
Metab Brain Dis. 2021 Apr;36(4):639-652
pubmed: 33464458
Neuropharmacology. 2013 Dec;75:155-63
pubmed: 23924692
Clin Drug Investig. 2021 Mar;41(3):211-220
pubmed: 33559102
Br J Pharmacol. 2016 Jan;173(1):53-65
pubmed: 26377899
Front Pharmacol. 2022 Jan 26;13:815950
pubmed: 35153788
Trends Pharmacol Sci. 2017 Mar;38(3):198-201
pubmed: 28089139
Curr Top Behav Neurosci. 2012;12:251-318
pubmed: 22367921
CNS Neurol Disord Drug Targets. 2017;16(5):541-553
pubmed: 28412918
Neuroscience. 2021 Feb 1;454:105-115
pubmed: 32950556
Neuropharmacology. 2021 Sep 1;195:108679
pubmed: 34157363
Nat Rev Neurosci. 2021 Apr;22(4):209-222
pubmed: 33608673
Sci Rep. 2018 Mar 14;8(1):4519
pubmed: 29540728
Pharmacol Biochem Behav. 2019 Jun;181:93-100
pubmed: 31063743
Life Sci. 2005 Dec 22;78(5):539-48
pubmed: 16199061
Neuropharmacology. 2020 May 1;167:107740
pubmed: 31437433
J Pharm Pharmacol. 2011 May;63(5):636-47
pubmed: 21492165
Brain Res. 2007 Feb 23;1134(1):162-70
pubmed: 17196181
Front Pharmacol. 2020 Dec 04;11:587604
pubmed: 33424597
Naunyn Schmiedebergs Arch Pharmacol. 2006 Feb;372(5):354-61
pubmed: 16489449
Psychopharmacology (Berl). 1996 Dec;128(3):280-92
pubmed: 8972548
Molecules. 2021 Oct 08;26(19):
pubmed: 34641624
Life Sci. 2011 Aug 1;89(5-6):165-70
pubmed: 21704641
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Dec 3;55:40-9
pubmed: 24681195
Methods Mol Biol. 2019;1916:69-74
pubmed: 30535682
Pharmaceutics. 2020 Mar 15;12(3):
pubmed: 32183416